Regal Investment Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Regal Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,524	Closed	-$231K	–	280
2015 Q4	$231K	Buy	3,524 +102	+3%	+$6.3K	0.06%	229
2015 Q3	$193K	Buy	+3,422	New	+$222K	0.05%	236
2013 Q3	–	Sell	-51	Closed	-$2K	–	936
2013 Q2	$2K	Buy	+51	New	+$1.99K	﹤0.01%	809

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Regal Investment Advisors's TEVA Position: Q1 2016 in Review

Regal Investment Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2016, closing a stake of 3,524 shares — an estimated $231K sold.

Regal Investment Advisors first reported a position in TEVA in Q2 2013 and held it in 3 quarters. The position peaked at $231K in Q4 2015. 837 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Regal Investment Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2016 after selling out during the quarter.
Regal Investment Advisors sold 3,524 Teva Pharmaceutical Industries Limited shares in Q1 2016, an estimated $231K.
Regal Investment Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 3 quarters.
Regal Investment Advisors's Teva Pharmaceutical Industries Limited position peaked at $231K in Q4 2015.
837 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2016.

Based on Regal Investment Advisors's 13F filing for Q1 2016, filed 16 May 2016.